These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31514546)

  • 1. Efficacy and safety of tratinterol hydrochloride tablets in bronchial asthma: a randomized double-blind and multicenter clinical trial.
    Kong L; Zhao Y; Wang Y; Chang X; Cui L; Gu G; Ma Z; Lu Q; Zhou L; Ding L; Wang Z; Shao Y; Tang H; Zhang C; Hui F; Mei X; Xin J; Huo J; Sun S; Zhu S; Yao C; Du G; Cheng M; Kang J
    J Asthma; 2021 Jan; 58(1):85-92. PubMed ID: 31514546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of tratinterol hydrochloride tablets in bronchial asthma: a multicenter, randomized, double-blind, dose-finding clinical trial.
    Kong L; Yuan Y; Shao Y; Sun S; Liu J; Kang J
    Clin Ther; 2014 Sep; 36(9):1195-204. PubMed ID: 25174283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Multicenter Clinical Study of Tratinterol Hydrochloride Tablets for the Treatment of Bronchial Asthma.
    Kong L; Liu J; Gu G; Huo J; Ma Z; Shao Y; Sun S; Yuan Y; Zhu S; Yao C; Du G; Cheng M; Kang J
    Clin Ther; 2015 Jun; 37(6):1248-58. PubMed ID: 25857594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Bioequivalence Between the New Procaterol Hydrochloride Hydrate Dry Powder Inhaler and the Approved Dry Powder Inhaler in Patients With Asthma in a Randomized, Double-Blind, Double-Dummy, Crossover Comparison Study: A Phase 3 Study.
    Shirai R; Suzaki Y; Sato K; Takeuchi Y; Tokimatsu I; Koga N; Kadota J; Ohashi K
    Clin Pharmacol Drug Dev; 2018 May; 7(4):392-399. PubMed ID: 28884969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover manner.
    Kawai M; Sakai A; Takaori S; Hiura A; Sakata N; Nakashima M; Miyamoto T
    Methods Find Exp Clin Pharmacol; 2005; 27(6):385-9. PubMed ID: 16179955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
    Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
    Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness.
    Nathan RA; Minkwitz MC; Bonuccelli CM
    Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ferguson GT; FitzGerald JM; Bleecker ER; Laviolette M; Bernstein D; LaForce C; Mansfield L; Barker P; Wu Y; Jison M; Goldman M;
    Lancet Respir Med; 2017 Jul; 5(7):568-576. PubMed ID: 28545978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
    Berkowitz R; Rachelefsky G; Harris AG; Chen R
    Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
    Kim MK; Lee SY; Park HS; Yoon HJ; Kim SH; Cho YJ; Yoo KH; Lee SK; Kim HK; Park JW; Park HW; Chung JH; Choi BW; Lee BJ; Chang YS; Jo EJ; Lee SY; Cho YS; Jee YK; Lee JM; Jung J; Park CS
    Clin Ther; 2018 Jul; 40(7):1096-1107.e1. PubMed ID: 29945738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
    Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
    BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
    Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
    Lin J; Kang J; Lee SH; Wang C; Zhou X; Crawford J; Jacques L; Stone S
    Respir Med; 2015 Jan; 109(1):44-53. PubMed ID: 25524507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.